BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2099686)

  • 1. [Severe pseudotumoral panniculitis in the child: cytophagic histiocytic panniculitis? Favorable outcome with chemotherapy].
    Labeille B; Pautard B; Pare F; Lok C; Gontier MF; Devauchelle B; Delobel J; Denoeux JP
    Ann Dermatol Venereol; 1990; 117(11):807-8. PubMed ID: 2099686
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytophagic histiocytic panniculitis].
    Shi J; Liu HR; Fang K
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):59-60. PubMed ID: 15796888
    [No Abstract]   [Full Text] [Related]  

  • 3. Successful treatment of cytophagic histiocytic panniculitis with modified CHOP-E. Cyclophosphamide, adriamycin, vincristine, predonisone, and etoposide.
    Matsue K; Itoh M; Tsukuda K; Miyazaki K; Kokubo T
    Am J Clin Oncol; 1994 Dec; 17(6):470-4. PubMed ID: 7977162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytophagic histiocytic panniculitis: a report of four cases.
    Pettersson T; Kariniemi AL; Tervonen S; Franssila K
    Br J Dermatol; 1992 Dec; 127(6):635-40. PubMed ID: 1282361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcutaneous panniculitic T-cell lymphoma and cytophagic histiocytic panniculitis.
    Yung A; Snow J; Jarrett P
    Australas J Dermatol; 2001 Aug; 42(3):183-7. PubMed ID: 11488712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subcutaneous panniculitic T cell lymphoma mimicking histiocytic cytophagic panniculitis in a child.
    Ali SK; Othman NM; Tagoe AB; Tulba AA
    Saudi Med J; 2000 Nov; 21(11):1074-7. PubMed ID: 11360073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous T-cell lymphoma: report of two cases.
    Wasik F; Kołodziej T; Jeleń M; Pejcz J
    J Eur Acad Dermatol Venereol; 1998 Jan; 10(1):62-6. PubMed ID: 9552760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytophagic histiocytic panniculitis--what is the best therapy?
    Okamura T; Niho Y
    Intern Med; 1999 Mar; 38(3):224-5. PubMed ID: 10337930
    [No Abstract]   [Full Text] [Related]  

  • 9. High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma.
    Alaibac M; Berti E; Pigozzi B; Chiarion V; Aversa S; Marino F; Peserico A
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S121-3. PubMed ID: 15858508
    [No Abstract]   [Full Text] [Related]  

  • 10. Autologous peripheral blood stem cell transplantation to treat CHOP-refractory aggressive subcutaneous panniculitis-like T cell lymphoma.
    Nakahashi H; Tsukamoto N; Yamane A; Saitoh T; Uchiumi H; Handa H; Karasawa M; Murakami H; Kojima M; Nojima Y
    Acta Haematol; 2009; 121(4):239-42. PubMed ID: 19556752
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term evolution of cytophagic histiocytic panniculitis.
    Rios Fernández R; Callejas Rubio JL; Sánchez Cano D; Dominguez Vicent JR; Linares Solano J; Ortego Centeno N
    J Cutan Med Surg; 2010; 14(3):136-40. PubMed ID: 20487674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Not all facial swellings are angioedemas!
    Fricker M; Dubach P; Helbling A; Diamantis E; Villiger PM; Novak U
    J Investig Allergol Clin Immunol; 2015; 25(2):146-7. PubMed ID: 25997314
    [No Abstract]   [Full Text] [Related]  

  • 13. Malignant histiocytosis resistant to anthracycline. Response to intensive treatment with etoposide and amsacrine.
    Abrams RA; Hanson G; Hansen R; Baumann MA; Anderson T
    Arch Intern Med; 1985 Apr; 145(4):742-3. PubMed ID: 3872645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A high tumor-associated macrophage content predicts favorable outcome in follicular lymphoma patients treated with rituximab and cyclophosphamide-doxorubicin-vincristine-prednisone.
    Taskinen M; Karjalainen-Lindsberg ML; Nyman H; Eerola LM; Leppä S
    Clin Cancer Res; 2007 Oct; 13(19):5784-9. PubMed ID: 17908969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mycosis fungoides bullosa.
    Natsuga K; Shimizu T; Abe R; Kodama K; Shimizu H
    Arch Dermatol; 2006 Jun; 142(6):793-5. PubMed ID: 16785397
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytophagic histiocytic panniculitis--a critical reappraisal.
    Wick MR; Patterson JW
    Arch Dermatol; 2000 Jul; 136(7):922-4. PubMed ID: 10890995
    [No Abstract]   [Full Text] [Related]  

  • 17. Histiocytic cytophagic panniculitis: a rare late complication of allogeneic bone marrow transplantation.
    Galende J; Vazquez ML; Almeida J; Peña Penabad MC; Fernandez Lopez E; Caballero MD; San Miguel JF
    Bone Marrow Transplant; 1994 Oct; 14(4):637-9. PubMed ID: 7858541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transformation of cutaneous gamma/delta T-cell lymphoma following 15 years of indolent behavior.
    Hosler GA; Liégeois N; Anhalt GJ; Moresi JM
    J Cutan Pathol; 2008 Nov; 35(11):1063-7. PubMed ID: 18544066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Case of malignant histiocytosis treated with chop therapy and splenectomy].
    Kitano Y; Nakagawa M; Kojima M; Kumagai H; Tani G; Komatsu M; Nara M; Nakano S; Oyashiki K; Toyama K
    Nihon Naika Gakkai Zasshi; 1994 Jun; 83(6):990-2. PubMed ID: 7964055
    [No Abstract]   [Full Text] [Related]  

  • 20. Cell kinetics and therapy in multiple myeloma: an update of the M83 protocol.
    Pileri A; Barbui T; Boccadoro M; Comotti B; Dammacco F; Gallamini A; Marmont F; Neretto G; Petrucci MT; Resegotti L
    Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():168-9. PubMed ID: 2713554
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.